Literature DB >> 17217616

Enhanced cell survival of gastric cancer cells by a novel gene URG4.

Jiugang Song1, Huahong Xie, Zhaorui Lian, Guitao Yang, Rui Du, Yulei Du, Xue Zou, HaiFeng Jin, Juan Gao, Jie Liu, Daiming Fan.   

Abstract

Upregulated gene 4 (URG4), a novel gene located on 7 chromosome (7p13), was found to contribute to hepatocarcinogenesis. However, the role of URG4 in the gastric carcinogenesis still remains unclear. In the present study, URG4 was found by immunohistochemistry to be upregulated in human gastric cancer tissues compared with matched adjacent nonneoplastic tissues. The proliferating cell nuclear antigen index is higher in gastric cancer tissues with high URG4 expression than in those with low URG4 expression. The growth of GES-1 cells, which are immortalized human gastric epithelial mucosa cells with baseline URG4 expression, was accelerated by URG4 induction. Downregulation of URG4 through URG4 small interfering RNA (siRNA) in SGC7901 and MKN28 cells, which had high endogenous URG4 expression, suppressed cell proliferation in both of these cells. URG4-siRNA also inhibited the proliferation of SGC7901 and MKN28 cells in soft agar and tumor formation in nude mice. Overexpression of URG4 in GES cells upregulated cyclin D1, whereas repression of URG4 in SGC7901 and MKN28 cells downregulated cyclin D1. The data suggested that URG4 played an important role in the development of human gastric cancer by regulating the expression of cyclin D1 and might be used as a potential therapeutic target for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217616      PMCID: PMC1783723          DOI: 10.1593/neo.06592

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  17 in total

1.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

2.  Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.

Authors:  Daniele Generali; Alfredo Berruti; Maria P Brizzi; Leticia Campo; Simone Bonardi; Simon Wigfield; Alessandra Bersiga; Giovanni Allevi; Manuela Milani; Sergio Aguggini; Valeria Gandolfi; Luigi Dogliotti; Alberto Bottini; Adrian L Harris; Stephen B Fox
Journal:  Clin Cancer Res       Date:  2006-08-01       Impact factor: 12.531

Review 3.  Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis.

Authors:  I B Weinstein
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

Review 4.  Disruption of oncogene/tumor suppressor networks during human carcinogenesis.

Authors:  Karl Münger
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

5.  Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication.

Authors:  T Rokkas; C Liatsos; A Karameris; E Petridou; A Lazaris; D Antoniades; E Kalafatis
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

6.  Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene.

Authors:  Pius Joseph; Yi-Xiong Lei; Wen-Zong Whong; Tong-man Ong
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

7.  Expression of seven main Rho family members in gastric carcinoma.

Authors:  Yanglin Pan; Feng Bi; Na Liu; Yan Xue; Xuebiao Yao; Yi Zheng; Daiming Fan
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

8.  Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis.

Authors:  K Maaser; P Däubler; B Barthel; B Heine; B von Lampe; H Stein; B Hoffmeister; H Scherer; H Scherübl
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

9.  Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene.

Authors:  Liu Hong; Yumei Zhang; Na Liu; Changjiang Liu; Min Zhi; Yanglin Pan; Mei Lan; Li Sun; Daiming Fan
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

Review 10.  Gastric cancer: epidemiology, pathology and treatment.

Authors:  S R Alberts; A Cervantes; C J H van de Velde
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

View more
  29 in total

1.  Temozolomide may induce cell cycle arrest by interacting with URG4/URGCP in SH-SY5Y neuroblastoma cells.

Authors:  Veli Çıtışlı; Yavuz Dodurga; Canan Eroğlu; Mücahit Seçme; Çığır Biray Avcı; N Lale Şatıroğlu-Tufan
Journal:  Tumour Biol       Date:  2015-04-03

2.  Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.

Authors:  Yavuz Dodurga; Gulsah Gundogdu; Volkan Tekin; Tugba Koc; N Lale Satiroglu-Tufan; Gulseren Bagci; Vural Kucukatay
Journal:  Mol Biol Rep       Date:  2014-03-21       Impact factor: 2.316

3.  Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.

Authors:  Yavuz Dodurga; G Nilufer Yonguc; Cigir Biray Avci; Gulseren Bagci; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

4.  Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.

Authors:  Cigir Biray Avci; Yavuz Dodurga; Gulsah Gundogdu; Hasan Onur Caglar; Vural Kucukatay; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Tumour Biol       Date:  2013-07-03

5.  SP1 is a transcriptional regulator of URG-4/URGCP gene in hepatocytes.

Authors:  Esra Tokay; Feray Kockar
Journal:  Mol Cell Biochem       Date:  2016-10-20       Impact factor: 3.396

6.  miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP.

Authors:  Tiefeng Qiu; Keping Wang; Xianwen Li; Jianhua Jin
Journal:  Exp Ther Med       Date:  2018-10-01       Impact factor: 2.447

7.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycin.

Authors:  Yavuz Dodurga; Cığır Biray Avcı; Sunde Yılmaz Susluer; N Lale Satıroğlu Tufan; Cumhur Gündüz
Journal:  Mol Biol Rep       Date:  2012-09-25       Impact factor: 2.316

9.  Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCP.

Authors:  Yavuz Dodurga; Canan Eroğlu; Mücahit Seçme; Levent Elmas; Çığır Biray Avcı; N Lale Şatıroğlu-Tufan
Journal:  Tumour Biol       Date:  2015-09-03

10.  URG4 expression in invasive breast carcinoma and its relation to clinicopathological characteristics.

Authors:  Figen Aslan; Ayla Solmaz Avcıkurt
Journal:  Breast Cancer       Date:  2019-01-24       Impact factor: 4.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.